Laddar...
Inhibition of human immunodeficiency virus type-1 by cdk inhibitors
Current therapy for human immunodeficiency virus (HIV-1) infection relies primarily on the administration of anti-retroviral nucleoside analogues, either alone or in combination with HIV-protease inhibitors. Although these drugs have a clinical benefit, continuous therapy with the drugs leads to dru...
Sparad:
| Huvudupphovsmän: | , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
BioMed Central
2010
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2852372/ https://ncbi.nlm.nih.gov/pubmed/20334651 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-6405-7-7 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|